{
    "title": "Hypercalcemia in infants with congenital hypothyroidism and its relation to vitamin D and thyroid hormones.",
    "doc_id": "3490559",
    "writer": "Tau C",
    "year": "1986",
    "summary": "Hypercalcemia before treatment did not appear to be related to the vitamin D status of the infant nor to an alteration in vitamin D metabolism, but to the presence of a residual thyroid secretion. In contrast, hypercalcemia during thyroxine therapy was â€¦",
    "abstract": "The circulating concentrations of calcium, phosphorus, and vitamin D metabolites were measured in 25 infants (fifteen to 30 days of age) with congenital hypothyroidism before treatment or during the first 6 months of thyroxine therapy. Five of the children before treatment and four during the early 3 months of treatment had mild hypercalcemia (10.8 to 12.4 mg/dl). Hypercalcemia before treatment did not appear to be related to the vitamin D status of the infant nor to an alteration in vitamin D metabolism, but to the presence of a residual thyroid secretion. In contrast, hypercalcemia during thyroxine therapy was related to vitamin D supplementation, even though the serum calcium concentration could not be correlated with the circulating concentration of any of the vitamin D metabolites assayed and obvious changes in vitamin D metabolism could not be demonstrated.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/3490559/",
    "clean_text": "hypercalcemia in infants with congenital hypothyroidism and its relation to vitamin d and thyroid hormones hypercalcemia before treatment did not appear to be related to the vitamin d status of the infant nor to an alteration in vitamin d metabolism but to the presence of a residual thyroid secretion in contrast hypercalcemia during thyroxine therapy was the circulating concentrations of calcium phosphorus and vitamin d metabolites were measured in infants fifteen to days of age with congenital hypothyroidism before treatment or during the first months of thyroxine therapy five of the children before treatment and four during the early months of treatment had mild hypercalcemia to mg dl hypercalcemia before treatment did not appear to be related to the vitamin d status of the infant nor to an alteration in vitamin d metabolism but to the presence of a residual thyroid secretion in contrast hypercalcemia during thyroxine therapy was related to vitamin d supplementation even though the serum calcium concentration could not be correlated with the circulating concentration of any of the vitamin d metabolites assayed and obvious changes in vitamin d metabolism could not be demonstrated"
}